71335-1772 Methotrexate - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

71335-1772

Brand Name:

Methotrexate

Generic Name:

Methotrexate

Dosage Form Name:

TABLET

Administration Route:

Oral

Substances:

Name: METHOTREXATE SODIUM

Strength: 2.5

Unit: mg/1

Packages:

Code: 71335-1772-01

Description: 30 TABLET in 1 BOTTLE (71335-1772-1)

Effective Date: Dec. 29, 2021

Discontinued:

Code: 71335-1772-02

Description: 12 TABLET in 1 BOTTLE (71335-1772-2)

Effective Date: Dec. 29, 2021

Discontinued:

Code: 71335-1772-03

Description: 20 TABLET in 1 BOTTLE (71335-1772-3)

Effective Date: Dec. 29, 2021

Discontinued:

Code: 71335-1772-04

Description: 100 TABLET in 1 BOTTLE (71335-1772-4)

Effective Date: Dec. 29, 2021

Discontinued:

Code: 71335-1772-05

Description: 36 TABLET in 1 BOTTLE (71335-1772-5)

Effective Date: Dec. 29, 2021

Discontinued:

Code: 71335-1772-06

Description: 24 TABLET in 1 BOTTLE (71335-1772-6)

Effective Date: Jan. 21, 2021

Discontinued:

Code: 71335-1772-07

Description: 90 TABLET in 1 BOTTLE (71335-1772-7)

Effective Date: Dec. 29, 2021

Discontinued:

Code: 71335-1772-08

Description: 4 TABLET in 1 BOTTLE (71335-1772-8)

Effective Date: Dec. 29, 2021

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Antimetabolite

Minor Class:

Folic Acid Analog

Orphan Drug Designation:

Status:

In Use